News headlines DocuSign (DOCU) faces scrutiny as analysts highlight concerns over its growth and valuation. Despite recent earnings that beat expectations, the stock remains under pressure from ...

Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases. The ...

DocuSign, Inc. engages in the provision of cloud-based electronic signature solutions, which helps companies and individuals securely collect information, automate data workflows, and sign anything.